
Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.
Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.
Factors independently associated with persistently active RA included age, gender, previous or current smoking status, and social deprivation.
At 12 weeks, significantly more patients with fibromyalgia receiving the smartphone-based intervention reported clinical improvements compared with the control group.
Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Of the 333 patients with psoriatic arthritis (PsA) and 457 patients with axial spondyloarthritis (axSpA), there were 1.09 serious infections per 100 patient-years.
At week 52, sustained remission was observed in significantly more patients receiving sarilumab compared with placebo.
Guidelines aim to help the identification of ILD in patients with rheumatic disease and aid in improving the management of patients.
Patients with IBD-RA and depression were younger, more likely to be female, and were more frequently White compared with controls.
Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.
Regardless of a prior history of swallowed topical corticosteroids, dupilumab was proven to be an effective treatment in patients with eosinophilic esophagitis.
Polypharmacy was significantly higher in patients with psoriatic arthritis when compared with controls, according to a new study.
Published: August 18th 2025 | Updated: August 25th 2025
Published: August 19th 2025 | Updated: August 22nd 2025
Published: June 6th 2025 | Updated: August 18th 2025
Published: June 27th 2025 | Updated: July 1st 2025
Published: February 20th 2025 | Updated: February 21st 2025
Published: January 16th 2025 | Updated: January 29th 2025
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.